Search

everythinglearnresearchcommunity

for

Search:↓

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Doctors need to be better prepared to assess and treat obesity in patients.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Modern hair transplants use small grafts for a natural look and drugs to prevent further loss, with high patient satisfaction.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Spiny mice are better at regenerating hair after injury than laboratory mice and could help us understand how to improve human skin repair.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.